美国血液净化学会主治医师小组委员会重要血液净化文章年度回顾。

IF 1.4 4区 医学 Q4 HEMATOLOGY
Yvette C. Tanhehco, Mohamed Alsammak, Ding Wen Wu, Victoria Costa, Vishesh Chhibber, Yosef Levenbrown, Yanhua Li, Wen Lu, Adela D. Mattiazzi, Laura D. Stephens, Daniel K. Noland, Marisa C. Saint Martin, Nirupama Singh, Nicole D. Zantek, Joanne Becker, Gay Wehrli
{"title":"美国血液净化学会主治医师小组委员会重要血液净化文章年度回顾。","authors":"Yvette C. Tanhehco,&nbsp;Mohamed Alsammak,&nbsp;Ding Wen Wu,&nbsp;Victoria Costa,&nbsp;Vishesh Chhibber,&nbsp;Yosef Levenbrown,&nbsp;Yanhua Li,&nbsp;Wen Lu,&nbsp;Adela D. Mattiazzi,&nbsp;Laura D. Stephens,&nbsp;Daniel K. Noland,&nbsp;Marisa C. Saint Martin,&nbsp;Nirupama Singh,&nbsp;Nicole D. Zantek,&nbsp;Joanne Becker,&nbsp;Gay Wehrli","doi":"10.1002/jca.22152","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>In this first annual review article, the American Society for Apheresis (ASFA) Attending Physician Subcommittee (APSc) of the Physicians' Committee (PC) curated key apheresis literature in 2023 and presented their choices for the 10 most seminal apheresis articles. PubMed and OVID search engines were used to identify manuscripts from four topic areas: donor apheresis, therapeutic apheresis, education, and cellular therapy. To further identify seminal criteria, they had to present at least one of the following: novel findings, practice-altering outcomes, international scope, randomized controlled trial, relevant to current clinical practice, and/or provide evidence for category III or IV indications based on the ASFA ninth special issue of the Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach. Inclusion criteria included: full-length, peer-reviewed, English language, and human subjects. Case reports, review articles, and meta-analyses were excluded.</p>\n </div>","PeriodicalId":15390,"journal":{"name":"Journal of Clinical Apheresis","volume":"39 6","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An Annual Review of Important Apheresis Articles From the American Society for Apheresis Attending Physician Subcommittee\",\"authors\":\"Yvette C. Tanhehco,&nbsp;Mohamed Alsammak,&nbsp;Ding Wen Wu,&nbsp;Victoria Costa,&nbsp;Vishesh Chhibber,&nbsp;Yosef Levenbrown,&nbsp;Yanhua Li,&nbsp;Wen Lu,&nbsp;Adela D. Mattiazzi,&nbsp;Laura D. Stephens,&nbsp;Daniel K. Noland,&nbsp;Marisa C. Saint Martin,&nbsp;Nirupama Singh,&nbsp;Nicole D. Zantek,&nbsp;Joanne Becker,&nbsp;Gay Wehrli\",\"doi\":\"10.1002/jca.22152\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n <p>In this first annual review article, the American Society for Apheresis (ASFA) Attending Physician Subcommittee (APSc) of the Physicians' Committee (PC) curated key apheresis literature in 2023 and presented their choices for the 10 most seminal apheresis articles. PubMed and OVID search engines were used to identify manuscripts from four topic areas: donor apheresis, therapeutic apheresis, education, and cellular therapy. To further identify seminal criteria, they had to present at least one of the following: novel findings, practice-altering outcomes, international scope, randomized controlled trial, relevant to current clinical practice, and/or provide evidence for category III or IV indications based on the ASFA ninth special issue of the Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach. Inclusion criteria included: full-length, peer-reviewed, English language, and human subjects. Case reports, review articles, and meta-analyses were excluded.</p>\\n </div>\",\"PeriodicalId\":15390,\"journal\":{\"name\":\"Journal of Clinical Apheresis\",\"volume\":\"39 6\",\"pages\":\"\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2024-11-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Apheresis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/jca.22152\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Apheresis","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jca.22152","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

在这篇首次年度综述文章中,美国血液净化学会(ASFA)医师委员会(PC)的主治医师小组委员会(APSc)对2023年的主要血液净化文献进行了梳理,并评选出了10篇最具开创性的血液净化文章。他们使用 PubMed 和 OVID 搜索引擎从四个主题领域中识别手稿:供体无细胞疗法、治疗性无细胞疗法、教育和细胞疗法。为了进一步确定开创性标准,这些文章必须至少提供以下一项:新发现、改变实践的结果、国际范围、随机对照试验、与当前临床实践相关,和/或根据ASFA第九期特刊《临床实践中使用治疗性血液透析的指导原则--基于证据的方法》为III类或IV类适应症提供证据。纳入标准包括:长篇、同行评审、英文、以人为研究对象。病例报告、综述文章和荟萃分析除外。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
An Annual Review of Important Apheresis Articles From the American Society for Apheresis Attending Physician Subcommittee

In this first annual review article, the American Society for Apheresis (ASFA) Attending Physician Subcommittee (APSc) of the Physicians' Committee (PC) curated key apheresis literature in 2023 and presented their choices for the 10 most seminal apheresis articles. PubMed and OVID search engines were used to identify manuscripts from four topic areas: donor apheresis, therapeutic apheresis, education, and cellular therapy. To further identify seminal criteria, they had to present at least one of the following: novel findings, practice-altering outcomes, international scope, randomized controlled trial, relevant to current clinical practice, and/or provide evidence for category III or IV indications based on the ASFA ninth special issue of the Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach. Inclusion criteria included: full-length, peer-reviewed, English language, and human subjects. Case reports, review articles, and meta-analyses were excluded.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.80
自引率
13.30%
发文量
70
审稿时长
>12 weeks
期刊介绍: The Journal of Clinical Apheresis publishes articles dealing with all aspects of hemapheresis. Articles welcomed for review include those reporting basic research and clinical applications of therapeutic plasma exchange, therapeutic cytapheresis, therapeutic absorption, blood component collection and transfusion, donor recruitment and safety, administration of hemapheresis centers, and innovative applications of hemapheresis technology. Experimental studies, clinical trials, case reports, and concise reviews will be welcomed.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信